ZYCLARA (imiquimod) 3.75% cream by Graceway Pharmaceuticals The FDA has approved Zyclara (imiquimod cream, from Graceway Pharmaceuticals) for the treatment of clinically typical, visible or ...

In addition, 31% of patients using Zyclara 2.5% cream had complete clearance of actinic keratoses versus 6% for the placebo group. Zyclara is already available in a 3.75% strength formulation.

The treatment of actinic keratosis depends on the specific case and severity of the symptoms. Possible options for treatment include topical creams and gels, cryotherapy, curettage and excision.

What's new concerning our understanding of actinic keratosis? Find out in this easy-to-navigate collection of recent MEDLINE abstracts compiled by the editors at Medscape Dermatology. Imiquimod 5% ...

April 1, 2010 — The US Food and Drug Administration (FDA) has approved imiquimod cream 3.75% (Zyclara, Graceway Pharmaceuticals) for the treatment of visible or palpable actinic keratoses. The ...

“As there is a risk of 0.025% to 16% per year for each actinic keratosis to progress to skin cancer, and it is not possible to predict which actinic keratosis will become cancerous, early ...

After a single course of treatment, topical fluorouracil cream, 5%, effectively reduced actinic keratosis counts and the long-term need for spot treatment in a high-risk population, according to ...

UPDATE ON SKIN CANCER: Actinic keratosis is one of the most common forms of skin disease in older people. About half of all skin cancers begin as actinic keratosis, according to health columnist Dr… ...

Actinic keratosis (AK) is the most frequent premalignant skin disease in the white population. AKs are thought to be caused by exposure to ultraviolet light (UVL). More darkly pigmented skin does ...

For instance, the combination of cryotherapy and fluorouracil cream exhibit a success rate of approximately 90% for the treatment of multiple actinic keratosis lesions.